Gender differences in non-glycemic responses to improved insulin sensitivity by pioglitazone treatment in patients with type 2 diabetes

By Arnetz Lisa   Dorkhan Mozhgan   Alvarsson Michael   Brismar Kerstin   Ekberg Neda  

Acta Diabetologica, Vol. 51, Iss. 2, 2014-04 ,pp. : 185-192

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Pioglitazone Add-On to Gliclazide and Metformin on Glycemic Control in Patients with Type 2 Diabetes

By Al-Azzam Sayer I.   AlOmari Mousa   Khader Yousef S.   AlMahasneh Fatimah A.   Muflih Suhaib M.   Altawalbeh Shoroq  

Endocrine Research, Vol. 37, Iss. 1, 2012-02 ,pp. : 7-11

Informa Healthcare

Access to resources Recommend Favorite

Spotlight on Pioglitazone in Type 2 Diabetes Mellitus

By Waugh John   Keating Gillian M.   Plosker Greg L.   Easthope Stephanie   Robinson Dean M.  

Treatments in Endocrinology, Vol. 5, Iss. 3, 2006-01 ,pp. : 189-191

Adis International

Access to resources Recommend Favorite

Addition of sitagliptin to ongoing glimepiride therapy in Japanese patients with type 2 diabetes over 52 weeks leads to improved glycemic control

By Tajima Naoko  

Diabetology International, Vol. 2, Iss. 1, 2011-03 ,pp. : 32-44

Springer Publishing Company

Access to resources Recommend Favorite

Multidisciplinary approach to patients with poorly controlled type 2 diabetes mellitus: a prospective, randomized study

By Maislos M.   Weisman D.  

Acta Diabetologica, Vol. 41, Iss. 2, 2004-06 ,pp. : 44-48

Springer Publishing Company

Access to resources Recommend Favorite